Search

This research aims to test and analyze the influence of agency costs, intellectual capital, managerial ownership, and institutional ownership on firm value with financial performance as a moderating variable. The population in this study are LQ45 index companies listed on the Indonesia Stock Exchange (BEI) for the 2020-2022 period. This research used a purposive sampling technique with a sample size of 18 companies for three consecutive years for a total of 54 observations. Partial research results show that agency costs and intellectual capital have no effect on firm value. Meanwhile, managerial ownership and institutional ownership have a positive effect on firm value. Financial performance is unable to moderate the influence of agency costs on firm value, nor is it able to moderate the influence of intellectual capital on firm value. However, financial performance can moderate the influence of managerial ownership and the influence of institutional ownership on firm value. [ABSTRACT FROM AUTHOR]

Coronavirus Disease (COVID-19), is an acute respiratory disease that has become a health crisis that threatens the world. A treatment plan that can aim to reduce the number of deaths caused by COVID-19 is needed and one of the potential treatments is stem cell therapy. In recent years, stem cell therapy has become an advancement in medicine with great opportunity for COVID-19 treatment because it is considered promising and cutting-edge in research. This literature review was constructed by comprehensive data searching in database PubMed and aims to provide an overview of mesenchymal stem cells and their potential in treating COVID-19. Mesenchymal stem cells are known to have regenerative, immunomodulation, and anti-inflammatory function. There are several challenges of mesenchymal stem cell therapy on COVID-19, such as their limited productibility in urgent situations like COVID-19 and it comes with a few health risks and precautions that should be taken into account. However, mesenchymal stem cell is still a promising therapy for COVID-19 because of their regeneration and tissue repair potential, potent immunomodulatory and anti-inflammatory properties, the lack of immune response in cell transplantation, and the lack of ACE2 receptor expression. [ABSTRACT FROM AUTHOR]